Isabelle Ducellier - BioGaia AB CEO Pres
| 0GTN Stock | 111.70 1.30 1.15% |
CEO
Isabelle Ducellier is CEO Pres of BioGaia AB ser
| Age | 55 |
| Address | Kungsbroplan 3, Stockholm, Sweden, 112 27 |
| Phone | 46 8 55 52 93 00 |
| Web | https://www.biogaia.com |
BioGaia AB Management Efficiency
The company has return on total asset (ROA) of 0.1318 % which means that it generated a profit of $0.1318 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1872 %, meaning that it generated $0.1872 on every $100 dollars invested by stockholders. BioGaia AB's management efficiency ratios could be used to measure how well BioGaia AB manages its routine affairs as well as how well it operates its assets and liabilities. At this time, BioGaia AB's Total Assets are comparatively stable compared to the past year. Other Assets is likely to gain to about 14.5 M in 2025, whereas Net Tangible Assets are likely to drop slightly above 1.3 B in 2025.Similar Executives
| Found 7 records | CEO Age | ||
| Shelley Simpson | JB Hunt Transport | 53 | |
| Christopher Winfrey | Charter Communications Cl | 49 | |
| Pete Raby | Morgan Advanced Materials | 58 | |
| Andrew Belshaw | Gamma Communications PLC | 51 | |
| Rgis Schultz | JD Sports Fashion | 57 | |
| Tobias Gimeno | Cellnex Telecom SA | 65 | |
| Marco Patuano | Cellnex Telecom SA | 61 | |
Management Performance
| Return On Equity | 0.19 | ||||
| Return On Asset | 0.13 |
BioGaia AB ser Leadership Team
Elected by the shareholders, the BioGaia AB's board of directors comprises two types of representatives: BioGaia AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioGaia. The board's role is to monitor BioGaia AB's management team and ensure that shareholders' interests are well served. BioGaia AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioGaia AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Eva Nelson, Co Mang | ||
| Isabelle Ducellier, CEO Pres | ||
| Ludvig Milesson, Chief Officer | ||
| Alexander M, Executive CFO | ||
| Jens Velling, Chief Officer | ||
| Gianfranco Grompone, Chief Development | ||
| Jonathan Gromark, Sustainability Manager | ||
| Sebastian Heimfors, VP Officer | ||
| MBA Econ, Founder Chairman | ||
| Marika Isberg, Regulatory Legal | ||
| Theresa Agnew, CEO President | ||
| Angelika Kjelldorff, Chief Officer | ||
| Caroline Mofors, Chief Officer | ||
| Linda Hagglund, Vice Marketing |
BioGaia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioGaia AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | ||||
| Return On Asset | 0.13 | ||||
| Profit Margin | 0.25 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 10.21 B | ||||
| Shares Owned By Insiders | 8.78 % | ||||
| Shares Owned By Institutions | 52.98 % | ||||
| Revenue | 1.42 B | ||||
| Gross Profit | 1.03 B | ||||
| EBITDA | 486.06 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for BioGaia Stock Analysis
When running BioGaia AB's price analysis, check to measure BioGaia AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioGaia AB is operating at the current time. Most of BioGaia AB's value examination focuses on studying past and present price action to predict the probability of BioGaia AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioGaia AB's price. Additionally, you may evaluate how the addition of BioGaia AB to your portfolios can decrease your overall portfolio volatility.